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“Man’s quest for knowledge is an expanding series whose 
limit is infinity, but philosophy seeks to attain that limit at 
one blow, by a short circuit providing the certainty of 
complete and inalterable truth. Science meanwhile advances 
at its gradual pace, often slowing to a crawl, and for periods 
it even walks in place, but eventually it reaches the various 
ultimate trenches dug by philosophical thought, and, quite 
heedless of the fact that it is not supposed to be able to cross 
those final barriers to the intellect, goes right on.” 
Stanisław Lem: His Master’s Voice (1968) 
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INTRODUCTION 
Impaired mitochondrial function is involved in trauma, 
neurodegeneration, ischemia/reperfusion or excitotoxicity. 
Depolarized mitochondria are thought to precipitate cell death 
by depleting cytosolic ATP pools. In several pathological 
settings, mitochondria indeed revert to ATP consumption, 
aggravating an existing cellular pathology. However, for as 
long as the inner mitochondrial membrane remains intact and 
ATP production is substantiated via matrix substrate-level 
phosphorylation by SUCL without eliciting the need of 
oxidative phosphorylation, mitochondrial consumption of 
cytosolic ATP is hindered. KGDHC provides succinyl-CoA for 
SUCL, thus supporting matrix substrate-level phosphorylation. 
Although a link has been establish between the decline in its 
activity and brain pathology, the molecular mechanisms 
underlying the propensity for neurodegeneration have not been 
published so far. Here it is proposed that as a result of KGDHC 
deficiency, the decreased provision of succinyl-CoA 
diminishes matrix substrate-level phosphorylation, resulting in 
impaired mitochondrial ATP output and consumption of 
cytosolic ATP by respiration-impaired mitochondria. Mindful 
of the reaction catalyzed by KGDHC converting α-
ketoglutarate, CoASH, and NAD+ to succinyl-CoA, NADH, 
and CO2, the question arises as to the source of NAD+, under 
conditions of a dysfunctional respiratory chain. It is a textbook 
definition that NADH generated in the citric acid cycle is 
oxidized by complex I, resupplying NAD+ to the cycle. In the 
absence of oxygen or when respiratory complexes are not 
functional, an excess of NADH in the matrix is expected. Yet, 
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previous reports of our group demonstrated that without 
NADH oxidation by complex I of the respiratory chain, 
substrate-level phosphorylation was operational and supported 
by succinyl-CoA, implying KGDHC activity. Alternative 
pathways for NADH oxidation during anoxia or pharmacologic 
blockade of complex I were therefore investigated, which are 
able to supply NAD+ to KGDHC, what in turn yields succinyl-
CoA, thus supporting substrate-level phosphorylation. 
During respiratory arrest, proton extrusion to the extra-
mitochondrial compartment by the reversed FOF1-ATP 
synthase contributes to the generation of ΔΨm at the expense 
of ATP hydrolysis. It has been reported recently by another 
group that CYPD binds to the FOF1-ATP synthase, resulting in 
a decrease in ATP synthesis and hydrolysis rates. Genetic 
ablation of CYPD or its inhibition by cyclosporin A led to a 
disinhibition of the complex, resulting in accelerated ATP 
synthesis and hydrolysis rates. However, these effects were 
demonstrated in either submitochondrial particles or 
alamethicin-permeabilized mitochondria, representing 
conditions under which there is direct access to the FOF1-ATP 
synthase. In intact mitochondria, changes in ATP synthesis or 
hydrolysis rates by the FOF1-ATP synthase do not necessarily 
translate to changes in ATP efflux or influx rates as a result of 
the presence of the ANT. The extent of contribution of CYPD 
on the rates of ADP and ATP fluxes towards the 
extramitochondrial compartment was therefore addressed in 
intact mitochondria to confirm and extend the result of the 
recent literature. 
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AIMS AND OBJECTIVES 
The outlined experiments were performed in order to find an 
answer to the following questions in particular: 
1. Does the CYPD bind to and modulate the FOF1-ATP 
synthase in intact mitochondria? 
2. Does the modulation of FOF1-ATP synthase by CYPD 
affect the ANT-mediated ADP-ATP exchange rates of 
intact mitochondria? 
3. Does the decreased succinyl-CoA provision by an 
impaired KGDHC affect the ANT-mediated ADP-ATP 
exchange rates of intact mitochondria respiring on 
substrates supporting substrate-level phosphorylation? 
4. Does the decreased succinyl-CoA provision by an 
impaired KGDHC diminish the matrix ATP/ADP ratio 
during respiratory failure enough for the ANT to reverse? 
5. Does the KGDHC-SUCL axis of the citric acid cycle 
operate even under conditions when complex I is unable to 
provide NAD+ for the KGDHC? 
6. Do mitochondrial diaphorases in the matrix contribute to 
the alternative regeneration of NAD+ for KGDHC during 
respiratory arrest? 
7. What other pathways exist during respiratory failure for 
NADH oxidation in the mitochondrial matrix? 
8. How does complex III block affect NAD+ provision of 
KGDHC by diaphorase activity during respiratory arrest? 
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MATERIALS AND METHODS 
Animals 
Mitochondria were prepared either from CYPD-/-, DLD+/-, 
DLST+/-, DLD+/-/DLST+/- and heart-specific superoxide 
dismutase 2 overexpressing transgenic or WT mice (Mus 
musculus) or from pigeons (Columba livia domestica). 
Preparation of isolated mitochondria 
Nonsynaptic brain mitochondria from mice were isolated by 
Percoll gradient purification. Mitochondria from the hearts and 
livers of all animals were isolated via differential 
centrifugation. The mitochondrial protein content was 
determined using the bicinchoninic acid assay, calibrated with 
bovine serum albumin standards, using a Tecan Infinite® 200 
PRO series plate reader. 
Isolation of synaptosomes from mouse brain 
Synaptosomes were prepared from mice by differential 
centrifugation using Percoll gradient. Protein content was 
determined using the bicinchoninic acid assay described above. 
Determination of mitochondrial membrane potential 
Mitochondrial membrane potential (ΔΨm) of isolated 
mitochondria was estimated using fluorescence quenching of 
the cationic dye safranin O, due to its accumulation inside the 
negatively charged matrix of energized mitochondria. 
Fluorescence was recorded in either a PTI Deltascan, or a 
Hitachi F-4500 or F-7000 fluorescence spectrophotometer. To 
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convert safranin O fluorescence into millivolts, a voltage-
fluorescence calibration curve was constructed. 
Alternatively, safranin O fluorescence was also detected – in 
parallel with oxygen consumption – using the O2k-
Fluorescence LED2-Module of the OROBOROS Oxygraph-2k. 
Estimation of ΔΨm from tetraphenylphosphonium (TPP+) ion 
distribution was measured using a custom-made TPP+-selective 
electrode. The electrode was calibrated by sequential additions 
of TPP+Cl−. 
ΔΨm of in situ mitochondria of synaptosomes was 
qualitatively estimated fluorimetrically by loading 
synaptosomes with the potentiometric fluorescent dye 
tetramethylrhodamine methyl ester (TMRM). Fluorescence 
was recorded in a Hitachi F-4500 fluorescence 
spectrophotometer. 
ΔΨm of in situ mitochondria of neurons was qualitatively 
determined by wide-field fluorescence imaging, or confocal 
imaging, using the fluorescence quenching of TMRM. All 
ΔΨm determinations of isolated, in situ synaptic and neuronal 
somal mitochondria were performed at 37°C. 
[Mg2+]free determination from Magnesium GreenTM 
fluorescence and its conversion to ADP-ATP exchange rate 
Isolated mitochondria were added to a cytosol-like incubation 
medium containing the Mg2+-sensitive fluorescent indicator 
Magnesium GreenTM (MgG) and magnesium. Changes in the 
[Mg2+]free of the medium were followed by measuring MgG 
fluorescence in a PTI Deltascan fluorescence 
spectrophotometer at 37°C. At the end of each experiment, 
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minimum and maximum fluorescence were recorded and used 
to convert the signal to [Mg2+]free by means of the Grynkiewicz 
equation. The ADP-ATP exchange rate was estimated using a 
method described by our group, exploiting the differential 
affinity of ADP and ATP to Mg2+. The rate of ATP appearing 
in the medium after the addition of ADP to energized 
mitochondria (or vice versa in the case of de-energized 
mitochondria) was calculated from the measured rate of change 
in the extramitochondrial [Mg2+]free using standard binding 
equations, combined in an executable file available for 
download at http://www.tinyurl.com/ANT-calculator. 
Mitochondrial respiration 
Oxygen consumption was monitored polarographically using 
an OROBOROS Oxygraph-2k. Experiments were performed at 
37°C. Oxygen concentration and flux were recorded and 
calculated using the DatLab software. 
Determination of extramitochondrial pH changes 
pH of the incubation medium of isolated mouse liver 
mitochondria was recorded by connecting a combination pH 
microelectrode to a BNC connector of the OROBOROS 
Oxygraph-2k. The medium had only minimal buffering 
capacity in order to allow the detection of the minor pH 
changes caused by mitochondrial CO2 production. The voltage 
signal output of the electrode was converted to pH by 
calibrating with MeterLab® certified standard solutions. 
Experiments were performed at 37°C; therefore temperature 
compensation was applied during voltage-pH calibration 
according to data provided by the manufacturer. 
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Mitochondrial matrix pH (pHi) determination 
The pHi of isolated liver mitochondria from WT and CYPD 
KO mice was estimated fluorimetrically by loading 
mitochondria with the ratiometric fluorescent dye BCECF-AM. 
Fluorescence of hydrolyzed BCECF trapped in the matrix was 
measured in a Hitachi F-4500 fluorescence spectrophotometer 
in a ratiometric mode, at 37°C. The BCECF signal was 
calibrated using buffers of known pH values, and by 
equilibrating matrix pH to that of the incubation medium by 
adding uncoupler plus nigericin. For converting BCECF 
fluorescence ratio to pH, an exponential function was fitted. 
Determination of NADH fluorescence 
Autofluorescence of reduced mitochondrial pyridine 
nucleotides was recorded in a Hitachi F-7000 fluorescence 
spectrophotometer at 37°C. 
Determination of KGDHC activity 
KGDHC activity was estimated fluorimetrically, detecting the 
autofluorescence of appearing NADH in the medium, due to 
NAD+ reduction by the complex at 30°C. The experiment was 
performed in a Hitachi F-4500 fluorescence spectrophotometer. 
Determination of SUCL activity 
ATP- and GTP-forming SUCL activities were estimated in the 
direction of succinyl-CoA to succinate reaction. The release of 
CoASH from succinyl-CoA was monitored 
spectrophotometrically on its reaction with DTNB at 30°C in a 
GBC UV/VIS 920 spectrophotometer. 
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Cross-linking, co-precipitation and western blotting 
To demonstrate the interaction between CYPD and FOF1-ATP 
synthase, intact mitochondria were incubated with the 
membrane-permeable cross-linker DSP in the absence or 
presence of cyclosporin A. Mitochondrial proteins were 
extracted with digitonin, immunoprecipitated with anti-
complex V sera, separated by SDS-PAGE, transferred to a 
methanol-activated polyvinylidene difluoride membrane and 
finally, immunocaptured proteins were tested for the presence 
of CYPD using the β-subunit of the FOF1-ATP synthase as 
loading control. 
Immunoreactivities of the SUCL subunits were demonstrated 
by using frozen mitochondrial and synaptosomal pellets, 
thawed on ice and separated by SDS-PAGE. Separated proteins 
were transferred to a methanol-activated polyvinylidene 
difluoride membrane. Immunoblotting was performed as 
recommended by the manufacturers of the antibodies. 
Immunoreactivity was detected in all cases by using the 
appropriate peroxidase-linked secondary antibodies and 
enhanced chemiluminescence detection reagent. 
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RESULTS 
Modulation of FO-F1 ATP synthase activity by CYPD 
regulates matrix adenine nucleotide levels 
ANT-mediated ADP-ATP exchange rates were measured in 
intact isolated WT and CYPD KO mouse liver mitochondria, 
both in the presence and absence of cyclosporin A and were 
compared with those obtained by direct ATP hydrolysis rates 
by the FOF1-ATP synthase in alamethicin-permeabilized 
mitochondria. There was no difference in the ATP efflux-ΔΨm 
profile of the WT compared to CYPD KO mice, whereas ANT 
was operating in the forward mode. Similarly, when 
mitochondria were completely depolarized, no statistically 
significant difference was observed between mitochondria 
isolated either from WT or CYPD KO mice during ATP influx, 
irrespective of the presence of cyclosporin A in the medium. 
However, if mitochondria were subsequently permeabilized by 
alamethicin, mitochondria isolated from CYPD KO mice 
exhibited a 30.9 ± 1.3% faster ATP hydrolysis rate compared 
to WT littermates. 
The CYPD-FOF1-ATP synthase interaction was demonstrated 
in intact isolated mitochondria using the membrane-permeable 
cross-linker DSP, followed by co-precipitation using an 
antibody for FOF1-ATP synthase as bait. Cyclosporin A was 
found to diminish the binding of CYPD on the FOF1-ATP 
synthase. 
Mathematical predictions afforded the assumption that a 30% 
increase in FOF1-ATP synthase activity would lead to an 
insignificant increase (1.38–1.7%) in the ANT-mediated ADP-
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ATP exchange rate in maximally polarized (forward mode of 
both ANT and FOF1-ATP synthase) and maximally depolarized 
(reverse mode of both ANT and FOF1-ATP synthase) 
mitochondria. 
Intact mouse liver mitochondria were de-energized by substrate 
deprivation in the presence of the specific complex I inhibitor 
rotenone, followed by the addition of ATP. ΔΨm was recorded 
in order to compare WT ± cyclosporin A vs. CYPD KO mice. 
Under these conditions, and as a result of the sufficiently low 
ΔΨm values before the addition of ATP, ANT and FOF1-ATP 
synthase operated in reverse mode. Provision of ATP led to its 
influx to mitochondria, followed by its hydrolysis by the 
reversed FOF1-ATP synthase, which in turn extruded protons to 
the extramitochondrial compartment, thus generating ΔΨm. In 
this setting, the ability of the FOF1-ATP synthase to pump 
protons out of the matrix represented the only component 
opposing the action of an uncoupler. Mitochondria isolated 
from the livers of CYPD KO mice resisted the uncoupler-
induced stepwise depolarization more than those obtained from 
WT littermates. Cyclosporin A also exhibited a similar effect 
on WT mitochondria but not on KO mice. 
The negative impact of KGDHC deficiency on matrix 
substrate-level phosphorylation 
To label a respiration-impaired mitochondrion as an 
extramitochondrial ATP provider or consumer, the effect of 
ANT inhibitors on ΔΨm during ADP-induced respiration was 
examined. Adenine nucleotide exchange through the ANT is 
electrogenic, since 1 molecule of ATP4- is exchanged for 1 
molecule of ADP3-. Therefore, during the forward mode of 
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ANT, abolition of its operation by an ANT inhibitor, such as 
carboxyatractyloside (cATR) or bongkrekate, will lead to a 
gain of ΔΨm, whereas during the reverse mode of ANT, 
abolition of its operation by the inhibitor will lead to a loss of 
ΔΨm. This biosensor test (i.e., the effect of cATR on isolated, 
or bongkrekate on in situ mitochondria obtained from WT, 
DLD+/-, DLST+/- and DLD+/-/DLST+/- mice) was used to 
address the directionality of ANT during respiratory inhibition. 
If respiratory substrates added to the medium supported matrix 
substrate-level phosphorylation, addition of cATR to 
respiration-impaired isolated liver or brain mitochondria 
obtained from WT mice resulted in the gain of ΔΨm, indicating 
that the ANT was operating in forward mode. On the other 
hand, addition of cATR to respiration-impaired isolated liver or 
brain mitochondria obtained from DLD+/-, DLST+/- and DLD+/-
/DLST+/- mice resulted in the loss of ΔΨm, implying that the 
ANT was operating in reverse mode despite the presence of 
substrate-level phosphorylation supporting substrates. 
ATP efflux rates of isolated liver and Percoll-purified brain 
mitochondria obtained from WT, DLD+/-, DLST+/- and DLD+/-
/DLST+/- mice were determined and compared. In KGDHC-
deficient mitochondria, those substrates supporting substrate-
level phosphorylation yielded lower ATP efflux rates than WT 
littermates; but for those substrates that support only weakly or 
not at all substrate-level phosphorylation, no statistically 
significant difference was found in the ATP efflux rates. 
Isolated nerve terminals (synaptosomes) and cultured cortical 
neurons were prepared from the brains of WT, DLD+/-, DLST+/- 
and DLD+/-/DLST+/- mice. Also, bongkrekate was used to 
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inhibit ANT instead of cATR, as the former can penetrate the 
plasma membrane, but the latter cannot. The biosensor test was 
applied to identify whether partially polarized in situ synaptic 
mitochondria – where substrate is an uncontrolled variable – 
consume extramitochondrial ATP. Addition of bongkrekate led 
to a robust repolarization in WT, DLD+/- and DLST+/- mice, 
implying that the ANT was still operating in the forward mode. 
Only in synaptosomes prepared from DLD+/-/DLST+/- mice did 
bongkrekate cause almost no repolarization, followed by a 
delayed minor depolarization. 
Results obtained from cultured cortical neurons from WT, 
DLD+/-, and DLST+/- mice show that when in situ mitochondria 
were inhibited by rotenone, subsequent addition of bongkrekate 
led to a repolarization in WT cultures, unlike in cultures 
obtained from DLD+/- and DLST+/- mice where a depolarization 
was observed. This implied that respiration-impaired in situ 
neuronal somal mitochondria of DLD+/- and DLST+/- mice were 
consuming extramitochondrial ATP. 
Alterations in KGDHC due to genetic manipulations could 
have an effect also on SUCL. Therefore, KGDHC activity and 
ATP- and GTP-forming activities of the two SUCL isoforms 
were measured in isolated liver and brain mitochondria and 
synaptosomes obtained from WT and transgenic mice, as well 
as immunoreactivities of all three subunits of SUCL. KGDHC 
activity of DLD+/- and DLST+/- liver and brain mitochondria 
was reduced by 20-48%, compared to WT littermates. KGDHC 
activity of DLD+/-/DLST+/- liver and brain mitochondria was 
reduced by 62 and 50%, respectively. On the contrary, ATP- 
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and GTP-forming maximal activities of the two SUCL 
isoforms were not different between WT and transgenic mice. 
Mitochondrial diaphorases as NAD+ donors to segments of 
the citric acid cycle that support substrate-level 
phosphorylation yielding ATP during respiratory arrest 
Using the recently developed O2k-Fluorescence LED2-Module 
of the OROBOROS Oxygraph-2k, it became possible to follow 
ΔΨm while measuring oxygen concentration in the same 
sample. Therefore, fundamental experiments establishing the 
basis of the previous chapter were repeated, hence at the time 
they were performed such technology was not available. The 
conclusion was drawn that in true anoxic conditions the ANT 
could be maintained in forward mode implying active matrix 
substrate-level phosphorylation in isolated mitochondria, 
similar to the paradigms with a poisoned respiratory chain. 
The effect of arsenite – which inhibits PDHC and KGDHC – 
was investigated on the rate of acidification in weakly buffered 
media. The concept of this experiment relied on the fact that 
mitochondria are net CO2 producers acidifying the medium as 
dissolving CO2 becomes carbonic acid. Depending on the 
substrate(s) combined with targeted inhibition of bioenergetic 
entities, the role of arsenite-inhibitable targets may be deduced. 
With substrate combinations bypassing PDHC, arsenite caused 
a statistically significant decrease in acidification in 
mitochondria pretreated with rotenone, cATR and oligomycin. 
The assumption was made that in mitochondria in which 
complex I is blocked by rotenone, the ANT and the FOF1-ATP 
synthase are blocked by cATR and oligomycin, respectively, 
the arsenite-inhibitable acidification may only stem from 
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KGDHC generating CO2. The CO2 production by KGDHC in 
respiration-impaired mitochondria suggested the availability of 
NAD+. Mindful of the above results, NAD+ sources in 
mitochondria other than that produced by complex I were 
sought for. 
To address the contribution of mitochondrial diaphorases to 
provision of NAD+ for KGDHC reaction in anoxia, 4 
pharmacological inhibitors were tested. First, the concentration 
range was established in which the compounds exhibited no 
appreciable uncoupling activity. The next step was to 
determine their effects in the biosensor test addressing the 
direction of ANT operation by recording the effect of cATR on 
ΔΨm in respiration-impaired isolated liver mitochondria. In the 
presence of diaphorase inhibitors, cATR induced 
depolarization without affecting the rate of respiration, 
implying ANT reversal. Likewise, in the presence of 
diaphorase inhibitors rotenone-treated mitochondria responded 
with depolarization to cATR, as compared to control or their 
vehicles showing cATR-induced repolarizations. 
The biosensor test was performed in the presence of known 
diaphorase substrates in mitochondria undergoing respiratory 
inhibition by anoxia or rotenone. 14 diaphorase substrates were 
tested in concentrations exhibiting no uncoupling or other side-
effects on ΔΨm or respiration rate. Mouse liver mitochondria 
were respiring on glutamate plus malate plus β-
hydroxybutyrate, a substrate combination that limited the 
availability of NAD+ during anoxic conditions. In this 
paradigm, dose-dependent addition of duroquinone during 
anoxia led to cATR-induced repolarization. When respiratory 
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inhibition was achieved by rotenone instead of anoxia, not only 
duroquinone, but menadione and mitoQ also resulted in a 
strong cATR-induced repolarization. There appeared to be a 
clear distinction between anoxia and rotenone-induced 
respiratory inhibition; in anoxia, menadione and mitoQ were 
not effective in conferring cATR-induced repolarization. The 
reason(s) for this were investigated further. 
To address the above discrepancy, mitochondrial respiration 
was inhibited with the specific complex III inhibitor 
stigmatellin. The rationale behind this relies on reports pointing 
to complex b of complex III as being capable of re-oxidizing 
substrates that are reduced by mitochondrial diaphorases. 
Stigmatellin was indeed negating the beneficial effect of 
diaphorase substrates assisting in cATR-induced repolarization. 
The diaphorase activity described for rodent and human tissues 
has been reported to be absent in the liver and breast muscle of 
pigeons. Isolated pigeon liver mitochondria were repolarized 
by cATR added after ADP and rotenone. The lack of 
diaphorase involvement in this effect was confirmed by the 
results that menadione failed to cause a more robust cATR-
induced repolarization, and none of the diaphorase inhibitors 
caused cATR-induced depolarization. Accordingly, 
duroquinone was without an effect on cATR-induced changes 
in ΔΨm of mitochondria during anoxia. These results support 
the conclusion that the effects of diaphorase substrates and 
inhibitors observed in mouse liver mitochondria were likely 
mediated through genuine diaphorase activity. Furthermore, it 
is apparent that in the absence of a diaphorase, pigeon liver 
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mitochondria were still able to maintain the KGDHC-SUCL 
axis sustaining substrate-level phosphorylation. 
Above data corroborate that mitochondrial diaphorases are not 
the sole providers for NAD+ during respiratory arrest. 
Therefore, alternative sources for NAD+ were considered. 
Heart mitochondria obtained from WT vs. heart-specific 
superoxide dismutase 2 overexpressing mice were compared 
by the biosensor test. These mice exhibit very low levels of 
reactive oxygen species emanation in cardiac mitochondria, in 
which cATR-induced a much smaller repolarization or even a 
depolarization, compared to WT littermates. From these results 
one can conclude that in the presence of rotenone, reactive 
oxygen species may assist in the regeneration of NAD+ in the 
mitochondrial matrix. 
It is possible that mitochondrial IDH isoforms may regenerate 
NAD+ during respiratory arrest: IDH2 converts α-ketoglutarate 
plus NAD(P)H to isocitrate plus NAD(P)+ and then IDH3 
oxidatively decarboxylates isocitrate plus NAD(P)+ to α-
ketoglutarate plus NAD(P)H. To address the extent of 
contribution of this IDH-mediated futility to mitochondrial 
NAD+ provision, it was attempted to shift the reaction towards 
NADH formation by manipulating the concentration of its 
substrates. It was reasoned that the presence of citrate in excess 
would negate the beneficial effect of other substrates 
supporting substrate-level phosphorylation in terms of cATR-
induced changes in ΔΨm during respiratory arrest. Indeed, 
addition of citrate to glutamate or α-ketoglutarate reverted the 
cATR-induced repolarization to a depolarization. 
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CONCLUSION 
The above results indicate that in case of submaximal 
uncoupling or impaired mitochondrial respiration, FOF1-ATP 
synthase may operate in reverse mode without the concomitant 
reversal of the ANT. Under these conditions matrix substrate-
level phosphorylation plays a critical role in supplying ATP for 
the reversed FOF1-ATP synthase, setting ΔΨm at a level just 
enough to prevent ANT reversal. The resultant prevention of 
cytosolic ATP consumption by dysfunctional mitochondria 
increases the survival chances of the harboring cell. 
ATP production by SUCL is not interrupted, moreover, it is 
activated during hypoxia. Considering the reasoning above, its 
adequate succinyl-CoA provision through KGDHC thus 
dissociates mitochondria with a dysfunctional respiratory chain 
from extramitochondrial ATP dependence. Relevant to this, in 
anoxia there is pronounced conversion of α-ketoglutarate to 
succinate, implying KGDHC operability. Therefore, alternative 
pathways providing NAD+ for KGDHC during impaired 
respiration have to exist, as NADH oxidation via complex I is 
impracticable. The final conclusion is that among other 
sources, mitochondrial diaphorases are the major contributors. 
CYPD binds to the FOF1-ATP synthase decreasing both ATP 
synthesis and hydrolysis rates. However, as a result of the 
imposing role of the ANT, this is not reflected in the 
extramitochondrial compartment. The modulation of FOF1-ATP 
synthase activity by CYPD rather represents a means of 
regulating the matrix ATP/ADP ratio, influencing both the 
ANT and the FOF1-ATP synthase. 
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ABBREVIATIONS 
ΔΨm:  mitochondrial membrane potential 
ADP:  adenosine 5’-(trihydrogen diphosphate) 
ANT:  adenine nucleotide translocase 
ATP:  adenosine 5’-(tetrahydrogen triphosphate) 
BCECF-AM: 2’,7’-bis-(2-carboxyethyl)-5-(and-6)-
carboxyfluorescein, acetoxymethyl ester 
cATR:  carboxyatractyloside 
CO2:  carbon dioxide 
CoASH: coenzyme A 
CYPD: cyclophilin D 
DLD:  dihydrolipoyl dehydrogenase 
DLST:  dihydrolipoyl succinyltransferase 
DSP:  3,3’-dithiobis(sulfosuccinimidyl propionate) 
DTNB: 5,5’-dithiobis(2-nitrobenzoic acid) 
GTP:  guanosine 5’-(tetrahydrogen triphosphate) 
IDH(2 or 3): isocitrate dehydrogenase, isoform 2 or 3 
KGDH(C): α-ketoglutarate dehydrogenase (complex) 
MgG:  Magnesium GreenTM, pentapotassium salt 
NAD(P)+: nicotinamide adenine dinucleotide (phosphate) 
PDH(C): pyruvate dehydrogenase (complex) 
SDS-PAGE: sodium dodecyl sulfate-polyacrylamide gel 
electrophoresis 
SUCL:  succinate-CoA ligase 
TMRM: tetramethylrhodamine methyl ester 
TPP:  tetraphenylphosphonium 
WT or KO: wild-type or knock-out 
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